WiSP Wissenschaftlicher Service Pharma GmbH

Quick facts

Phase 3 pipeline

• Anthracycline/dexamethasone-based induction chemotherapy · Oncology
  Anthracycline chemotherapy intercalates into DNA to prevent replication, while dexamethasone suppresses immune-mediated inflammation and enhances chemotherapy efficacy.
• Dexamethasone for control of symptoms · Immunology / Inflammation
  Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm.

Phase 2 pipeline

• paclitaxel plus trastuzumab

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• WiSP Wissenschaftlicher Service Pharma GmbH portfolio CI brief
• WiSP Wissenschaftlicher Service Pharma GmbH pipeline updates RSS